REFERENCES
- Department of Health and Human Services. 21 CFR Ch. 1 (4-1-94 edition), 291.505 (1994). Food and Drug Administration
- Saxon A. J., Calsyn D. A., Haver V. M., et al. A nationwide survey of urinalysis practices of methadone maintenance clinics: utilization of laboratory services. Arch. Pathol. Lab. Med. 1990; 114: 94–100
- Schwartz R. H. Urine testing in the detection of drugs of abuse. Arch. Int. Med. 1988; 148: 2407–2412
- Honour J. W. Testing for drug abuse. Lancet 1996; 348: 41–43
- Jain R. B. Design of clinical trials for treatment of opiate dependence: what is missing. NIDA Res. Monogr 1992; 128: 29–36
- Cone E. J., Dickerson S. L. Efficacy of urinalysis in monitoring heroin and cocaine abuse patterns: implications in clinical trials for treatment of drug dependence. NIDA Res. Monogr 1992; 128: 46–58
- Compton P. A., Ling W., Wesson D. R., et al. Urine toxicology as an outcome measure in drug abuse clinical trials: must every sample be analyzed. J. Addict. Dis. 1996; 15: 85–92